aluates Reports

$ 0.0

Automative

Global Medications for Fibromyalgia Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-4Q13185

Global Medications for Fibromyalgia Market Research Report 2023

BUY CHAPTERS

Global Medications for Fibromyalgia Market Research Report 2025

Code: QYRE-Auto-4Q13185

Report

May 2025

Pages:87

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Eli Lilly and Company

AbbVie

Sanofi

GlaxoSmithKline PLC

Bayer

Virios Therapeutics

Aptinyx Inc

FSD Pharma

TONIX Pharmaceuticals Holdings Corp

Teva Pharmaceutical Industries

Teva Pharmaceutical Industries Ltd

Johnson & Johnson Services

Medications for Fibromyalgia Market Size

The global market for Medications for Fibromyalgia was valued at US$ 3520 million in the year 2024 and is projected to reach a revised size of US$ 4524 million by 2031, growing at a CAGR of 3.7% during the forecast period.

Medications for Fibromyalgia Market

Fibromyalgia is a chronic condition characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, and tenderness in specific areas of the body. The management of fibromyalgia often involves a multidisciplinary approach, combining medications, lifestyle changes, and other therapies. It"s important to note that there is no cure for fibromyalgia, and treatment aims to alleviate symptoms and improve the quality of life.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Medications for Fibromyalgia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medications for Fibromyalgia.

The Medications for Fibromyalgia market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Medications for Fibromyalgia market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Medications for Fibromyalgia companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Medications for Fibromyalgia Market Report

Report Metric	Details
Report Name	Medications for Fibromyalgia Market
Accounted market size in year	US$ 3520 million
Forecasted market size in 2031	US$ 4524 million
CAGR	3.7%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Muscle Relaxants Analgesics Others
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Eli Lilly and Company, AbbVie, Teva Pharmaceutical Industries Ltd., Johnson & Johnson Services, Sanofi, GlaxoSmithKline, Bayer AG, TONIX Pharmaceuticals Holdings Corp, Virios Therapeutics, Aptinyx, FSD Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Medications for Fibromyalgia company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Medications for Fibromyalgia Market growing?

Ans: The Medications for Fibromyalgia Market witnessing a CAGR of 3.7% during the forecast period 2025-2031.

What is the Medications for Fibromyalgia Market size in 2031?

Ans: The Medications for Fibromyalgia Market size in 2031 will be US$ 4524 million.

Who are the main players in the Medications for Fibromyalgia Market report?

Ans: The main players in the Medications for Fibromyalgia Market are Pfizer, Eli Lilly and Company, AbbVie, Teva Pharmaceutical Industries Ltd., Johnson & Johnson Services, Sanofi, GlaxoSmithKline, Bayer AG, TONIX Pharmaceuticals Holdings Corp, Virios Therapeutics, Aptinyx, FSD Pharma

What are the Application segmentation covered in the Medications for Fibromyalgia Market report?

Ans: The Applications covered in the Medications for Fibromyalgia Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Medications for Fibromyalgia Market report?

Ans: The Types covered in the Medications for Fibromyalgia Market report are Muscle Relaxants, Analgesics, Others

Recommended Reports

Pain Management Drugs

Fibromyalgia & Musculoskeletal

Chronic Disease Therapeutics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Medications for Fibromyalgia Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Muscle Relaxants

1.2.3 Analgesics

1.2.4 Others

1.3 Market by Application

1.3.1 Global Medications for Fibromyalgia Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Medications for Fibromyalgia Market Perspective (2020-2031)

2.2 Global Medications for Fibromyalgia Growth Trends by Region

2.2.1 Global Medications for Fibromyalgia Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Medications for Fibromyalgia Historic Market Size by Region (2020-2025)

2.2.3 Medications for Fibromyalgia Forecasted Market Size by Region (2026-2031)

2.3 Medications for Fibromyalgia Market Dynamics

2.3.1 Medications for Fibromyalgia Industry Trends

2.3.2 Medications for Fibromyalgia Market Drivers

2.3.3 Medications for Fibromyalgia Market Challenges

2.3.4 Medications for Fibromyalgia Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Medications for Fibromyalgia Players by Revenue

3.1.1 Global Top Medications for Fibromyalgia Players by Revenue (2020-2025)

3.1.2 Global Medications for Fibromyalgia Revenue Market Share by Players (2020-2025)

3.2 Global Medications for Fibromyalgia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Medications for Fibromyalgia Revenue

3.4 Global Medications for Fibromyalgia Market Concentration Ratio

3.4.1 Global Medications for Fibromyalgia Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Medications for Fibromyalgia Revenue in 2024

3.5 Global Key Players of Medications for Fibromyalgia Head office and Area Served

3.6 Global Key Players of Medications for Fibromyalgia, Product and Application

3.7 Global Key Players of Medications for Fibromyalgia, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Medications for Fibromyalgia Breakdown Data by Type

4.1 Global Medications for Fibromyalgia Historic Market Size by Type (2020-2025)

4.2 Global Medications for Fibromyalgia Forecasted Market Size by Type (2026-2031)

5 Medications for Fibromyalgia Breakdown Data by Application

5.1 Global Medications for Fibromyalgia Historic Market Size by Application (2020-2025)

5.2 Global Medications for Fibromyalgia Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Medications for Fibromyalgia Market Size (2020-2031)

6.2 North America Medications for Fibromyalgia Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Medications for Fibromyalgia Market Size by Country (2020-2025)

6.4 North America Medications for Fibromyalgia Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Medications for Fibromyalgia Market Size (2020-2031)

7.2 Europe Medications for Fibromyalgia Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Medications for Fibromyalgia Market Size by Country (2020-2025)

7.4 Europe Medications for Fibromyalgia Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Medications for Fibromyalgia Market Size (2020-2031)

8.2 Asia-Pacific Medications for Fibromyalgia Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Medications for Fibromyalgia Market Size by Region (2020-2025)

8.4 Asia-Pacific Medications for Fibromyalgia Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Medications for Fibromyalgia Market Size (2020-2031)

9.2 Latin America Medications for Fibromyalgia Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Medications for Fibromyalgia Market Size by Country (2020-2025)

9.4 Latin America Medications for Fibromyalgia Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Medications for Fibromyalgia Market Size (2020-2031)

10.2 Middle East & Africa Medications for Fibromyalgia Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Medications for Fibromyalgia Market Size by Country (2020-2025)

10.4 Middle East & Africa Medications for Fibromyalgia Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Medications for Fibromyalgia Introduction

11.1.4 Pfizer Revenue in Medications for Fibromyalgia Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Eli Lilly and Company

11.2.1 Eli Lilly and Company Company Details

11.2.2 Eli Lilly and Company Business Overview

11.2.3 Eli Lilly and Company Medications for Fibromyalgia Introduction

11.2.4 Eli Lilly and Company Revenue in Medications for Fibromyalgia Business (2020-2025)

11.2.5 Eli Lilly and Company Recent Development

11.3 AbbVie

11.3.1 AbbVie Company Details

11.3.2 AbbVie Business Overview

11.3.3 AbbVie Medications for Fibromyalgia Introduction

11.3.4 AbbVie Revenue in Medications for Fibromyalgia Business (2020-2025)

11.3.5 AbbVie Recent Development

11.4 Teva Pharmaceutical Industries Ltd.

11.4.1 Teva Pharmaceutical Industries Ltd. Company Details

11.4.2 Teva Pharmaceutical Industries Ltd. Business Overview

11.4.3 Teva Pharmaceutical Industries Ltd. Medications for Fibromyalgia Introduction

11.4.4 Teva Pharmaceutical Industries Ltd. Revenue in Medications for Fibromyalgia Business (2020-2025)

11.4.5 Teva Pharmaceutical Industries Ltd. Recent Development

11.5 Johnson & Johnson Services

11.5.1 Johnson & Johnson Services Company Details

11.5.2 Johnson & Johnson Services Business Overview

11.5.3 Johnson & Johnson Services Medications for Fibromyalgia Introduction

11.5.4 Johnson & Johnson Services Revenue in Medications for Fibromyalgia Business (2020-2025)

11.5.5 Johnson & Johnson Services Recent Development

11.6 Sanofi

11.6.1 Sanofi Company Details

11.6.2 Sanofi Business Overview

11.6.3 Sanofi Medications for Fibromyalgia Introduction

11.6.4 Sanofi Revenue in Medications for Fibromyalgia Business (2020-2025)

11.6.5 Sanofi Recent Development

11.7 GlaxoSmithKline

11.7.1 GlaxoSmithKline Company Details

11.7.2 GlaxoSmithKline Business Overview

11.7.3 GlaxoSmithKline Medications for Fibromyalgia Introduction

11.7.4 GlaxoSmithKline Revenue in Medications for Fibromyalgia Business (2020-2025)

11.7.5 GlaxoSmithKline Recent Development

11.8 Bayer AG

11.8.1 Bayer AG Company Details

11.8.2 Bayer AG Business Overview

11.8.3 Bayer AG Medications for Fibromyalgia Introduction

11.8.4 Bayer AG Revenue in Medications for Fibromyalgia Business (2020-2025)

11.8.5 Bayer AG Recent Development

11.9 TONIX Pharmaceuticals Holdings Corp

11.9.1 TONIX Pharmaceuticals Holdings Corp Company Details

11.9.2 TONIX Pharmaceuticals Holdings Corp Business Overview

11.9.3 TONIX Pharmaceuticals Holdings Corp Medications for Fibromyalgia Introduction

11.9.4 TONIX Pharmaceuticals Holdings Corp Revenue in Medications for Fibromyalgia Business (2020-2025)

11.9.5 TONIX Pharmaceuticals Holdings Corp Recent Development

11.10 Virios Therapeutics

11.10.1 Virios Therapeutics Company Details

11.10.2 Virios Therapeutics Business Overview

11.10.3 Virios Therapeutics Medications for Fibromyalgia Introduction

11.10.4 Virios Therapeutics Revenue in Medications for Fibromyalgia Business (2020-2025)

11.10.5 Virios Therapeutics Recent Development

11.11 Aptinyx

11.11.1 Aptinyx Company Details

11.11.2 Aptinyx Business Overview

11.11.3 Aptinyx Medications for Fibromyalgia Introduction

11.11.4 Aptinyx Revenue in Medications for Fibromyalgia Business (2020-2025)

11.11.5 Aptinyx Recent Development

11.12 FSD Pharma

11.12.1 FSD Pharma Company Details

11.12.2 FSD Pharma Business Overview

11.12.3 FSD Pharma Medications for Fibromyalgia Introduction

11.12.4 FSD Pharma Revenue in Medications for Fibromyalgia Business (2020-2025)

11.12.5 FSD Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Eli Lilly and Company

AbbVie

Sanofi

GlaxoSmithKline PLC

Bayer

Virios Therapeutics

Aptinyx Inc

FSD Pharma

TONIX Pharmaceuticals Holdings Corp

Teva Pharmaceutical Industries

Teva Pharmaceutical Industries Ltd

Johnson & Johnson Services

List of Tables

Table 1. Global Medications for Fibromyalgia Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Muscle Relaxants

Table 3. Key Players of Analgesics

Table 4. Key Players of Others

Table 5. Global Medications for Fibromyalgia Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Medications for Fibromyalgia Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Medications for Fibromyalgia Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Medications for Fibromyalgia Market Share by Region (2020-2025)

Table 9. Global Medications for Fibromyalgia Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Medications for Fibromyalgia Market Share by Region (2026-2031)

Table 11. Medications for Fibromyalgia Market Trends

Table 12. Medications for Fibromyalgia Market Drivers

Table 13. Medications for Fibromyalgia Market Challenges

Table 14. Medications for Fibromyalgia Market Restraints

Table 15. Global Medications for Fibromyalgia Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Medications for Fibromyalgia Market Share by Players (2020-2025)

Table 17. Global Top Medications for Fibromyalgia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medications for Fibromyalgia as of 2024)

Table 18. Ranking of Global Top Medications for Fibromyalgia Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Medications for Fibromyalgia Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Medications for Fibromyalgia, Headquarters and Area Served

Table 21. Global Key Players of Medications for Fibromyalgia, Product and Application

Table 22. Global Key Players of Medications for Fibromyalgia, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Medications for Fibromyalgia Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Medications for Fibromyalgia Revenue Market Share by Type (2020-2025)

Table 26. Global Medications for Fibromyalgia Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Medications for Fibromyalgia Revenue Market Share by Type (2026-2031)

Table 28. Global Medications for Fibromyalgia Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Medications for Fibromyalgia Revenue Market Share by Application (2020-2025)

Table 30. Global Medications for Fibromyalgia Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Medications for Fibromyalgia Revenue Market Share by Application (2026-2031)

Table 32. North America Medications for Fibromyalgia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Medications for Fibromyalgia Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Medications for Fibromyalgia Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Medications for Fibromyalgia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Medications for Fibromyalgia Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Medications for Fibromyalgia Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Medications for Fibromyalgia Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Medications for Fibromyalgia Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Medications for Fibromyalgia Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Medications for Fibromyalgia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Medications for Fibromyalgia Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Medications for Fibromyalgia Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Medications for Fibromyalgia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Medications for Fibromyalgia Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Medications for Fibromyalgia Market Size by Country (2026-2031) & (US$ Million)

Table 47. Pfizer Company Details

Table 48. Pfizer Business Overview

Table 49. Pfizer Medications for Fibromyalgia Product

Table 50. Pfizer Revenue in Medications for Fibromyalgia Business (2020-2025) & (US$ Million)

Table 51. Pfizer Recent Development

Table 52. Eli Lilly and Company Company Details

Table 53. Eli Lilly and Company Business Overview

Table 54. Eli Lilly and Company Medications for Fibromyalgia Product

Table 55. Eli Lilly and Company Revenue in Medications for Fibromyalgia Business (2020-2025) & (US$ Million)

Table 56. Eli Lilly and Company Recent Development

Table 57. AbbVie Company Details

Table 58. AbbVie Business Overview

Table 59. AbbVie Medications for Fibromyalgia Product

Table 60. AbbVie Revenue in Medications for Fibromyalgia Business (2020-2025) & (US$ Million)

Table 61. AbbVie Recent Development

Table 62. Teva Pharmaceutical Industries Ltd. Company Details

Table 63. Teva Pharmaceutical Industries Ltd. Business Overview

Table 64. Teva Pharmaceutical Industries Ltd. Medications for Fibromyalgia Product

Table 65. Teva Pharmaceutical Industries Ltd. Revenue in Medications for Fibromyalgia Business (2020-2025) & (US$ Million)

Table 66. Teva Pharmaceutical Industries Ltd. Recent Development

Table 67. Johnson & Johnson Services Company Details

Table 68. Johnson & Johnson Services Business Overview

Table 69. Johnson & Johnson Services Medications for Fibromyalgia Product

Table 70. Johnson & Johnson Services Revenue in Medications for Fibromyalgia Business (2020-2025) & (US$ Million)

Table 71. Johnson & Johnson Services Recent Development

Table 72. Sanofi Company Details

Table 73. Sanofi Business Overview

Table 74. Sanofi Medications for Fibromyalgia Product

Table 75. Sanofi Revenue in Medications for Fibromyalgia Business (2020-2025) & (US$ Million)

Table 76. Sanofi Recent Development

Table 77. GlaxoSmithKline Company Details

Table 78. GlaxoSmithKline Business Overview

Table 79. GlaxoSmithKline Medications for Fibromyalgia Product

Table 80. GlaxoSmithKline Revenue in Medications for Fibromyalgia Business (2020-2025) & (US$ Million)

Table 81. GlaxoSmithKline Recent Development

Table 82. Bayer AG Company Details

Table 83. Bayer AG Business Overview

Table 84. Bayer AG Medications for Fibromyalgia Product

Table 85. Bayer AG Revenue in Medications for Fibromyalgia Business (2020-2025) & (US$ Million)

Table 86. Bayer AG Recent Development

Table 87. TONIX Pharmaceuticals Holdings Corp Company Details

Table 88. TONIX Pharmaceuticals Holdings Corp Business Overview

Table 89. TONIX Pharmaceuticals Holdings Corp Medications for Fibromyalgia Product

Table 90. TONIX Pharmaceuticals Holdings Corp Revenue in Medications for Fibromyalgia Business (2020-2025) & (US$ Million)

Table 91. TONIX Pharmaceuticals Holdings Corp Recent Development

Table 92. Virios Therapeutics Company Details

Table 93. Virios Therapeutics Business Overview

Table 94. Virios Therapeutics Medications for Fibromyalgia Product

Table 95. Virios Therapeutics Revenue in Medications for Fibromyalgia Business (2020-2025) & (US$ Million)

Table 96. Virios Therapeutics Recent Development

Table 97. Aptinyx Company Details

Table 98. Aptinyx Business Overview

Table 99. Aptinyx Medications for Fibromyalgia Product

Table 100. Aptinyx Revenue in Medications for Fibromyalgia Business (2020-2025) & (US$ Million)

Table 101. Aptinyx Recent Development

Table 102. FSD Pharma Company Details

Table 103. FSD Pharma Business Overview

Table 104. FSD Pharma Medications for Fibromyalgia Product

Table 105. FSD Pharma Revenue in Medications for Fibromyalgia Business (2020-2025) & (US$ Million)

Table 106. FSD Pharma Recent Development

Table 107. Research Programs/Design for This Report

Table 108. Key Data Information from Secondary Sources

Table 109. Key Data Information from Primary Sources

Table 110. Authors List of This Report

List of Figures

Figure 1. Medications for Fibromyalgia Picture

Figure 2. Global Medications for Fibromyalgia Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Medications for Fibromyalgia Market Share by Type: 2024 VS 2031

Figure 4. Muscle Relaxants Features

Figure 5. Analgesics Features

Figure 6. Others Features

Figure 7. Global Medications for Fibromyalgia Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Medications for Fibromyalgia Market Share by Application: 2024 VS 2031

Figure 9. Hospital Case Studies

Figure 10. Clinic Case Studies

Figure 11. Others Case Studies

Figure 12. Medications for Fibromyalgia Report Years Considered

Figure 13. Global Medications for Fibromyalgia Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Medications for Fibromyalgia Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Medications for Fibromyalgia Market Share by Region: 2024 VS 2031

Figure 16. Global Medications for Fibromyalgia Market Share by Players in 2024

Figure 17. Global Top Medications for Fibromyalgia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medications for Fibromyalgia as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Medications for Fibromyalgia Revenue in 2024

Figure 19. North America Medications for Fibromyalgia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Medications for Fibromyalgia Market Share by Country (2020-2031)

Figure 21. United States Medications for Fibromyalgia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Medications for Fibromyalgia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Medications for Fibromyalgia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Medications for Fibromyalgia Market Share by Country (2020-2031)

Figure 25. Germany Medications for Fibromyalgia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Medications for Fibromyalgia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Medications for Fibromyalgia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Medications for Fibromyalgia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Medications for Fibromyalgia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Medications for Fibromyalgia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Medications for Fibromyalgia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Medications for Fibromyalgia Market Share by Region (2020-2031)

Figure 33. China Medications for Fibromyalgia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Medications for Fibromyalgia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Medications for Fibromyalgia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Medications for Fibromyalgia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Medications for Fibromyalgia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Medications for Fibromyalgia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Medications for Fibromyalgia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Medications for Fibromyalgia Market Share by Country (2020-2031)

Figure 41. Mexico Medications for Fibromyalgia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Medications for Fibromyalgia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Medications for Fibromyalgia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Medications for Fibromyalgia Market Share by Country (2020-2031)

Figure 45. Turkey Medications for Fibromyalgia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Medications for Fibromyalgia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Medications for Fibromyalgia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Pfizer Revenue Growth Rate in Medications for Fibromyalgia Business (2020-2025)

Figure 49. Eli Lilly and Company Revenue Growth Rate in Medications for Fibromyalgia Business (2020-2025)

Figure 50. AbbVie Revenue Growth Rate in Medications for Fibromyalgia Business (2020-2025)

Figure 51. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Medications for Fibromyalgia Business (2020-2025)

Figure 52. Johnson & Johnson Services Revenue Growth Rate in Medications for Fibromyalgia Business (2020-2025)

Figure 53. Sanofi Revenue Growth Rate in Medications for Fibromyalgia Business (2020-2025)

Figure 54. GlaxoSmithKline Revenue Growth Rate in Medications for Fibromyalgia Business (2020-2025)

Figure 55. Bayer AG Revenue Growth Rate in Medications for Fibromyalgia Business (2020-2025)

Figure 56. TONIX Pharmaceuticals Holdings Corp Revenue Growth Rate in Medications for Fibromyalgia Business (2020-2025)

Figure 57. Virios Therapeutics Revenue Growth Rate in Medications for Fibromyalgia Business (2020-2025)

Figure 58. Aptinyx Revenue Growth Rate in Medications for Fibromyalgia Business (2020-2025)

Figure 59. FSD Pharma Revenue Growth Rate in Medications for Fibromyalgia Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Fibromyalgia Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Fibromyalgia Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Fibromyalgia Antidepressant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Chronic Pain Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pain Relief Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pain Therapy Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prescription Pain Relievers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Fibrate Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Arthritis Pain Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rheumatic Disorders Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anti Migraine Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pain Relievers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chronic Pain Management Drugs Market Research Report 2025

Back and Spine Pain Treatment Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Chronic Low Back Pain Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Idiopathic Pulmonary Fibrosis Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Non opioid Topical Pain Relief Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Fibrocystic Breasts Diagnostics and Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Neck Pain Treatment Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions